InSite Vision has reached an agreement with the FDA on a Special Protocol Assessment for the design of a Phase 3 clinical trial of treatment in patients with blepharitis.
NeoStem said Thursday that equity research firm Rodman & Renshaw re-iterated the multi-faceted stem cell company’s market outperform rating, based on “multiple milestones to drive shareholder value”.
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction.
ImmunoCellular Therapeutics will present positive results from a phase 1 clinical study on its ICT-107 therapy, a treatment for a type of brain tumor.
The fear of having cancer is not unfounded as the incidence of skin cancer is increasing at an alarming rate due in large part by UV exposure or excessive sun burn.
In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.
Access Pharmaceuticals announced Tuesday it has signed an agreement with eMax Health Systems to expand the distribution of the company’s MuGard treatment.
Valeant Pharmaceuticals said Tuesday that it agreed to buy Lithuania-based generic drug company Sanitas for €314 million in cash.
Threshold Pharmaceuticals takes advantage of the differences in metabolic activity between cancerous and normal, healthy biological tissue.
During an average life span of 70 years, the human heart will pump more than 400 million litres of blood.
Copyright © 2025 | WordPress Theme by MH Themes